CapitolRadar tracks every publicly disclosed CSL trade by US congress members and corporate insiders: 23 disclosed trades (11 buys, 12 sells) by 2 tracked traders, from 2021-03-12 to 2026-06-18. Updated daily from official filings.
Want a ping when Congress buys CSL? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
Carlisle Companies Incorporated (CSL) — Basic Materials · Construction Materials, market cap about $12.9B.
Cluster watch: 2 distinct tracked traders disclosed buying CSL in the last 45 days: Frias James D (director), Ricard Corrine D. (director).
CapitolRadar analysis
23 trades split almost evenly: 11 buys, 12 sells
Carlisle Companies Incorporated (CSL), in Basic Materials / Construction Materials, has 23 tracked trades from March 12, 2021 through June 18, 2026. The direction is nearly balanced: 11 buys and 12 sells across two distinct traders. That leaves sells ahead by one transaction, but the sample is small and concentrated among only two people, limiting broader conclusions about congressional trading sentiment.
The disclosed activity should also be read with timing and valuation caveats. Congressional transaction disclosures can carry a 45-day reporting lag, so public visibility may come well after the trade date. Transaction amount ranges, when disclosed, are estimates rather than exact trade values; no dollar ranges are included in the supplied CSL facts.
11 buys came from McCaul and Khanna
Michael McCaul accounts for nine of the 11 tracked buys, with his latest listed purchase dated September 22, 2025. Ro Khanna accounts for the other two buys, most recently on April 11, 2022. Together, those counts cover every CSL buy in the dataset. The facts do not identify the seller breakdown, transaction sizes or motivations, so the one-trade sell majority cannot be attributed further.
Both CSL buyers also purchased WDAY, META, SWK, BAX, DELL and SPGI. This overlap shows that the same two buyers appeared in each of those names, but it does not establish why they traded them or whether the purchases were related.
9 trades appear in the listed quarterly snapshots
The supplied quarterly entries are sparse and nonconsecutive. The first quarter of 2023 had two trades, including one buy. The second and fourth quarters of 2023 each had one trade, both buys. Each listed 2024 quarter—Q1, Q3 and Q4—had one trade and zero buys. The third quarter of 2025 had one buy, while the second quarter of 2026 had one trade and zero buys. These nine quarterly observations represent only part of the 23-trade history, so they should not be treated as a complete quarter-by-quarter series.
Analysis written from the tracked record on 2026-09-03; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q2 | 1 | 0 | 1 |
| 2025 Q3 | 1 | 1 | 0 |
| 2024 Q4 | 1 | 0 | 1 |
| 2024 Q3 | 1 | 0 | 1 |
| 2024 Q1 | 1 | 0 | 1 |
| 2023 Q4 | 1 | 1 | 0 |
| 2023 Q2 | 1 | 1 | 0 |
| 2023 Q1 | 2 | 1 | 1 |
Who is buying CSL?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Michael McCaul | 9 | 2025-09-22 | — |
| Ro Khanna | 2 | 2022-04-11 | — |
Disclosed trades in CSL
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-06-18 | Michael McCaul | sell | $1,001 - $15,000 | — |
| 2025-09-22 | Michael McCaul | buy | $15,001 - $50,000 | — |
| 2024-10-10 | Michael McCaul | sell | $15,001 - $50,000 | — |
| 2024-08-26 | Michael McCaul | sell | $1,001 - $15,000 | — |
| 2024-03-15 | Michael McCaul | sell | $50,001 - $100,000 | — |
| 2023-11-01 | Michael McCaul | buy | $15,001 - $50,000 | — |
| 2023-05-04 | Michael McCaul | buy | $1,001 - $15,000 | — |
| 2023-03-16 | Michael McCaul | buy | $15,001 - $50,000 | — |
| 2023-02-10 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2022-12-14 | Michael McCaul | sell | $1,001 - $15,000 | — |
| 2022-11-03 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2022-09-02 | Michael McCaul | sell | $50,001 - $100,000 | — |
| 2022-08-23 | Michael McCaul | sell | $50,001 - $100,000 | — |
| 2022-08-16 | Michael McCaul | sell | $15,001 - $50,000 | — |
| 2022-06-29 | Michael McCaul | buy | $1,001 - $15,000 | — |
| 2022-04-11 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2022-03-31 | Michael McCaul | buy | $100,001 - $250,000 | — |
| 2022-03-31 | Michael McCaul | buy | $50,001 - $100,000 | — |
| 2022-02-15 | Michael McCaul | buy | $1,001 - $15,000 | — |
| 2022-01-28 | Michael McCaul | sell | $1,001 - $15,000 | — |
These buyers also bought
Other stocks the tracked buyers of CSL disclosed buying in the last six months: META (2) · DHR (2) · MA (2) · AJG (2) · WDAY (2) · DELL (2).
About Carlisle Companies Incorporated
Carlisle Companies Incorporated operates as a manufacturer and supplier of building envelope products and solutions in the United States, Europe, North America, and internationally. It operates through two segments, Carlisle Construction Materials (CCM) and Carlisle Weatherproofing Technologies (CWT). The CCM segment offers single-ply roofing solutions, including ethylene propylene diene monomer, thermoplastic polyolefin, polyvinyl chloride membrane, polyiso insulation, and engineered metal roofing and wall panel systems for commercial and residential buildings. Its CWT segment provides waterp…
Frequently asked questions
Which politicians bought CSL most?
Michael McCaul leads with 9 disclosed buys, followed by Ro Khanna.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.